MFDS — authorised 25 July 2000
- Status: likely_approved
🇰🇷 Abreva in South Korea
MFDS authorised Abreva on 25 July 2000
Marketing authorisation
Abreva in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Dermatology approved in South Korea
Frequently asked questions
Is Abreva approved in South Korea?
Yes. MFDS authorised it on 25 July 2000.
Who is the marketing authorisation holder for Abreva in South Korea?
Marketing authorisation holder not available in our data.